Correlation Between Avadel Pharmaceuticals and Summit Materials

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and Summit Materials at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and Summit Materials into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and Summit Materials, you can compare the effects of market volatilities on Avadel Pharmaceuticals and Summit Materials and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of Summit Materials. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and Summit Materials.

Diversification Opportunities for Avadel Pharmaceuticals and Summit Materials

-0.46

Correlation Coefficient

Avadel Pharmaceuticals  Summit Materials

Very good diversification

The 3 months correlation between Avadel and Summit is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and Summit Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Materials and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with Summit Materials. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Materials has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and Summit Materials go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and Summit Materials

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to generate 4.73 times more return on investment than Summit Materials. However, Avadel Pharmaceuticals is 4.73 times more volatile than Summit Materials. It trades about 0.08 of its potential returns per unit of risk. Summit Materials is currently generating about 0.21 per unit of risk. If you would invest  1,032  in Avadel Pharmaceuticals PLC on October 12, 2024 and sell it today you would earn a total of  37.00  from holding Avadel Pharmaceuticals PLC or generate 3.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  Summit Materials

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Summit Materials

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Materials are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Summit Materials displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Avadel Pharmaceuticals and Summit Materials

The main advantage of trading using opposite Avadel Pharmaceuticals and Summit Materials positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, Summit Materials can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Materials will offset losses from the drop in Summit Materials' long position.

The idea behind Avadel Pharmaceuticals PLC and Summit Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.